BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6315823)

  • 1. Humoral antibody response to individual viral proteins after murine cytomegalovirus infection.
    Selgrade MK; Huang YS; Graham JA; Huang CH; Hu PC
    J Immunol; 1983 Dec; 131(6):3032-5. PubMed ID: 6315823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoblot analysis of the antibody response to murine cytomegalovirus in genetically resistant and susceptible mice.
    Farrell HE; Shellam GR
    J Gen Virol; 1989 Oct; 70 ( Pt 10)():2573-86. PubMed ID: 2552004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
    Jankowski M; Styczyński P
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis.
    Lawson CM; O'Donoghue HL; Reed WD
    Immunology; 1992 Mar; 75(3):513-9. PubMed ID: 1315309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between antibody titres against human cytomegalovirus detected by enzyme immunoassay and titres to individual viral polypeptides studied by immunoblotting.
    Mirolo G; Landini MP; Baldassarri B; Re MC; Lazzarotto T; La Placa M
    Microbiologica; 1986 Jul; 9(3):373-9. PubMed ID: 3018455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, characterization, and expression of the murine cytomegalovirus homologue of the human cytomegalovirus 28-kDa matrix phosphoprotein (UL99).
    Cranmer LD; Clark C; Spector DH
    Virology; 1994 Dec; 205(2):417-29. PubMed ID: 7975245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies.
    Bartholomaeus WN; O'Donoghue H; Foti D; Lawson CM; Shellam GR; Reed WD
    Immunology; 1988 Jul; 64(3):397-405. PubMed ID: 2842252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of serum antibodies against different classes of murine cytomegalovirus--induced antigens and virus isolation following a primary infection.
    Coppolecchia P; Furlini G; Re MC; Landini MP
    Microbiologica; 1983 Apr; 6(2):175-9. PubMed ID: 6306403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human antibody response to human cytomegalovirus-specific DNA-binding proteins.
    Gergely L; Czeglédy J; Váczi L
    Acta Virol; 1988 Jan; 32(1):1-5. PubMed ID: 2897767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.
    Farrell HE; Vally H; Lynch DM; Fleming P; Shellam GR; Scalzo AA; Davis-Poynter NJ
    Nature; 1997 Apr; 386(6624):510-4. PubMed ID: 9087412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine cytomegalovirus infection model in Balb/c mice. 3. Immunoglobulin production during infection.
    Leung WC; Hashimoto K; Umehara K; Hata J
    Tokai J Exp Clin Med; 1991 Mar; 16(1):11-20. PubMed ID: 1664146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral infection-homograft interactions in a murine model.
    Hamilton JD; Fitzwilliam JF; Cheung KS; Shelburne J; Lang DJ; Amos DB
    J Clin Invest; 1978 Dec; 62(6):1303-12. PubMed ID: 219027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence.
    Lenzo JC; Fairweather D; Cull V; Shellam GR; James Lawson CM
    J Mol Cell Cardiol; 2002 Jun; 34(6):629-40. PubMed ID: 12054850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen.
    Forman SJ; Zaia JA; Clark BR; Wright CL; Mills BJ; Pottathil R; Racklin BC; Gallagher MT; Welte K; Blume KG
    J Immunol; 1985 May; 134(5):3391-5. PubMed ID: 2580024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
    Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
    Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus.
    Reddehase MJ; Keil GM; Koszinowski UH
    J Immunol; 1984 Jan; 132(1):482-9. PubMed ID: 6317749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of ocular murine cytomegalovirus infection.
    Hayashi K; Kurihara I; Uchida Y
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):486-93. PubMed ID: 2984137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricted antibody diversity to major viral proteins of herpes simplex virus in individual syngeneic mice.
    McKendall RR
    J Immunol; 1990 Jul; 145(2):644-9. PubMed ID: 2164065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.